dendritic cell-MART-1 peptide vaccine

BIOLOGICAL3 trials

Sponsors

National Cancer Institute (NCI), Jonsson Comprehensive Cancer Center

Conditions

MelanomaMelanoma (Skin)

Phase 1

Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma

CompletedNCT00005617

Jonsson Comprehensive Cancer CenterMelanoma

Start: 1997-07-31Updated: 2020-08-03

Vaccine Therapy in Treating Patients With Stage IV or Recurrent Malignant Melanoma

CompletedNCT00039325

Jonsson Comprehensive Cancer CenterMelanoma (Skin)

Start: 2002-03-31End: 2009-06-30Updated: 2020-08-03

Vaccine Therapy in Treating Patients With Stage IV Melanoma

CompletedNCT00003665

National Cancer Institute (NCI)Melanoma (Skin)

Start: 1999-04-30End: 2002-11-30Updated: 2013-02-28